Abstract:RATIONALEMethotrexate (MTX) is an antineoplastic therapeutic medicine that acts as an antimetabolite of folic acid. In this study we identified the impurities in MTX drug substances produced by different manufacturers and in different batches using high‐performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry (HPLC‐PDA/FTICR‐MS).METHODSMTX and its impurities were separated on a Restek Pinnacle II C18 column (250 × 4.6 mm, 5 µm) with a gradient elution system composed of 0.2% formic acid and acetonitrile at a flow rate of 1.0 mL/min. Ultraviolet (UV) detection was set at 305 nm. Mass detection was carried out using FTICR‐MS with full‐scan mass analysis at a resolving power of 100 000 coupled with multiple‐stage mass analysis using a parent list of compounds.RESULTSFifteen impurities were detected in MTX drug substances, and their structures were predicted from using HPLC‐PDA/FTICR‐MS data, including their UV spectra, high‐resolution mass spectrometry (HRMS), fragmentation patterns, and MSn spectra. Ten of the impurities detected in the MTX drug substances are reported for the first time. There was a high abundance of esterified impurities in some batches of MTX drug substances, over the identification threshold of International Conference on Harmonization (ICH) guidelines, which requires particular attention.CONCLUSIONSThis paper describes a HPLC‐PDA/FTICR‐MS method to profile and identify impurities in MTX drug substances. The results suggest that HPLC‐PDA/FTICR‐MS is a valuable analytical technique for the rapid identification of impurities. Copyright © 2013 John Wiley & Sons, Ltd.

Synthesis of Three Impurities from Methotrexate

Synthesis of the related impurities of Trimethoprim

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Identification of Impurities in Methotrexate Drug Substances Using High-Performance Liquid Chromatography Coupled with A Photodiode Array Detector and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry

Synthesis of Five Deuterium Substituted 2-pyrimidinyloxy-N-arylbenzylamines with Herbicidal activity

Separation, Determination of Six Impurities in Methotrexate Drug Substance Using Ultra-Performance Liquid Chromatography

The Research of General Reaction: Synthesis of Erythromycin Derivatives Impurities about N-demonomethyl Compounds

THE SYNTHESIS OF 1-SULFOMETHYLTETRAZOLE-5-THIOL DISODIUM SALT

Improvement in Synthesis of 3’-N-demethylazithromycin and Its Derivatives

An Improved Synthesis of Inhibitor for Thymidylate Synthase Raltitrexed

Improved Synthesis of Trimetazidine Hydrochloride

Synthesis and Structure Characterization of Three Pharmaceutical Compounds Based on Tinidazole

Detection, identification, characterization, and high-performance liquid chromatography quantification of five impurities from a methazolamide product

Identification, Synthesis, and Comprehension of an Imidazole N-3 Regioisomeric Impurity of Olmesartan Medoxomil Key Intermediate

Preparation and Characterization of Impurity F of Acemetacin and Acematacin Monohydate

Identification and quantitative analysis of genotoxic impurities in rifampicin: Development and validation of a targeted LC-MS/MS method for 1-amino-4-methylpiperazine

The Synthesis,Characterization and Biological Activity of Three Pyridyl Triazole

Synthesis and evaluation of 8-deaza-5,6,7,8-tetrahydromethotrexate derivatives as dihydrofolate reductase inhibitors

Synthesis and Separation of the Clarithromycin A (E)-9-o-methyl Oxime

Identification, Synthesis And Strategy For Minimization Of Potential Impurities In The Synthesis Of Suvorexant

[Improved Synthesis Process of Diethyl N-[4-[(2,4-diaminopyrido[3,2-d]pyrimidin-6-yl)methylamino]benzoyl]-L-glutamate].